Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 6:33 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 889–912 of 121,433 matching trials from the live ClinicalTrials.gov search.

Filters: Completed Clear all

Conditions: Nicotine Dependence
Interventions: GW468816, Placebo Comparator: Placebo; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 264 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 2
States / cities: Belmont, Massachusetts • Boston, Massachusetts

Conditions: Mental Health Wellness
Interventions: Lactobacillus reuteri, Placebo; Dietary Supplement · Other
Lead sponsor: Elizabeth Austen Lawson; Other
Eligibility: 18 Years and older · Female only
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Trichotillomania, Hair Pulling
Interventions: N-Acetylcysteine, Placebo; Drug
Lead sponsor: Yale University; Other
Eligibility: 8 Years to 17 Years
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia
Interventions: cabozantinib; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Healthy
Interventions: Maraviroc, Fosamprenavir, Ritonavir; Drug
Lead sponsor: Garden State Infectious Disease Associates, PA; Other
Eligibility: 18 Years to 64 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: Voorhees Township, New Jersey

Conditions: Postoperative Pain
Interventions: HTX-011, Luer lock applicator, Vial access device, Ibuprofen, Acetaminophen, Ketorolac; Drug · Device
Lead sponsor: Heron Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 5
States / cities: Anaheim, California • Pasadena, California • Draper, Utah + 2 more

Conditions: Missing Tooth
Interventions: Minimally Traumatic Tooth Extraction, Immediate Implant Placement, Bone Graft Placement, Membrane placement, Collagen plug placement, Medications; Procedure · Device · Biological + 1 more
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 100 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Movement Disorders, Aging
Interventions: Exercise poles; Device
Lead sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); NIH
Eligibility: 65 Years to 80 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2007
U.S. locations: 1
States / cities: Muncie, Indiana

Conditions: Multiple Sclerosis, Exposure During Pregnancy
Interventions: Dimethyl fumarate, Peginterferon beta-1a; Drug
Lead sponsor: Biogen; Industry
Eligibility: Female only
Enrollment: 408 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2022
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Hypercholesterolemia, Hydroxy-methylglutaryl-coenzyme A (HMG Co-A) Reductase Inhibitors Adverse Reaction
Interventions: SLCO1B1*5 allele testing, results reported at randomization, SLCO1B1*5 allele testing, results reported at end of study, Genetic testing for SLCO1B1*5 allele; Genetic
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 167 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 2
States / cities: Travis Air Force Base, California • Durham, North Carolina

Conditions: Radial Head Fracture
Interventions: Outpatient physical therapy in addition to standard follow-up visits, Home exercises in addition to standard follow-up visits; Procedure · Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 99 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Knee Range of Motion
Interventions: Not listed
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 18 Years and older
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Auburn Hills, Michigan

Conditions: Pulp Necrosis, Regeneration
Interventions: Triple Antibiotic Paste, Standard Treatment; Drug · Other
Lead sponsor: Kenneth Hargreaves; Other
Eligibility: 6 Years to 20 Years
Enrollment: 125 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 4
States / cities: Loma Linda, California • Baltimore, Maryland • Chapel Hill, North Carolina + 1 more

Conditions: Feeding, Metabolism, Indirect Calorimetry, Blood Flow Velocity, Pulse Wave Analysis, Pulse Wave Velocity, Carbohydrate Metabolism, Fatty Acid Metabolism, Healthy Participants
Interventions: Mixed Meal Feeding Challenge; Other
Lead sponsor: George Washington University; Other
Eligibility: 18 Years to 45 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Metastatic Renal Cell Carcinoma, Metastatic Melanoma
Interventions: Aldesleukin; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 4
States / cities: Los Angeles, California • Aurora, Colorado • Louisville, Kentucky + 1 more

Conditions: HIV Infections
Interventions: Treatment regimen change; Behavioral
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 13 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2005
U.S. locations: 23
States / cities: Menlo Park, California • Stanford, California • Torrance, California + 15 more

Conditions: Infections, Bacterial, Sepsis, Alert Fatigue, Health Personnel
Interventions: Epic Best Practice Alert; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 420 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Enamel Erosion
Interventions: Stannous fluoride dentifrice, Positive control dentifrice, Negative control dentifrice; Drug
Lead sponsor: Procter and Gamble; Industry
Eligibility: 18 Years and older
Enrollment: 172 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Streptococcal Sore Throat
Interventions: Not listed
Lead sponsor: IQuum, Inc.; Industry
Eligibility: 3 Years and older
Enrollment: 799 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 5
States / cities: Norwich, Connecticut • Savannah, Georgia • Rochester, New York + 2 more

Conditions: Infections, Respiratory, Fever, Cough
Interventions: Testing Sensitivity for SARS-CoV-2 Virus in Symptomatic Individuals; Diagnostic Test
Lead sponsor: UnitedHealth Group; Industry
Eligibility: Not listed
Enrollment: 530 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Pneumonia, Community Acquired Pneumonia, Hospital Acquired Pneumonia, Acute Lung Injury
Interventions: ticagrelor, placebo; Drug
Lead sponsor: University of Kentucky; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 2
States / cities: Lexington, Kentucky

Conditions: Dry Eye Disease
Interventions: PL9643 Ophthalmic Solution, Placebo Ophthalmic Solution; Drug
Lead sponsor: ORA, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 4
States / cities: Andover, Massachusetts • Raynham, Massachusetts • Shelby, North Carolina + 1 more

Conditions: Melanoma
Interventions: Non-Interventional; Other
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years and older
Enrollment: 501 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: SARS-CoV-2, COVID-19
Interventions: Not listed
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 2,824 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Palo Alto, California

Search by objective public record fields.

Effectiveness of GW468816, an NMDA Glycine Site Antagonist, for Prevention of Relapse to Smoking

Study of Probiotic Use After Childbirth in Relation to Emotional Well-Being

N-Acetylcysteine for Pediatric Trichotillomania

Phase I Trial of Cabozantinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

An Interaction Study to Assess Drug Levels in Healthy Adult Subjects

Phase 2 Herniorrhaphy Study for Opioid Elimination

Guided Bone Regeneration Around Immediate Implants

Effects of Exercise Poles on Older Adults During Exercise Walking

Biogen Multiple Sclerosis Pregnancy Exposure Registry

Genetically Guided Statin Therapy

Functional Outcomes After Radial Head Fractures Treated Non-operatively

Mymobility Knee ROM

Regeneration of Pulp-Dentin Development in Teeth With Necrotic Pulps and Immature Roots

Effect of Caloric Content and Timing of Meal on Postprandial Substrate Oxidation and Pulse Wave Analysis

Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Effects of Changing HIV Therapy at Lower Versus Higher Viral Loads

Effect of BPA on Anchor Antibiotic Continuity in the ED: Randomized Controlled Trial

Meta-analysis of Stannous Fluoride and the Effects on Enamel Erosion

In Vitro Diagnostic Device for the Detection of Strep A

Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals

Targeting Platelet-Leukocyte Aggregates in Pneumonia With Ticagrelor

Efficacy and Safety of PL9643 Ophthalmic Solution in Subjects With Dry Eye

A Study is to Understand the Treatment Patterns for Immunotherapy Agents and BRAF/MEK Inhibitors Used in the Treatment of Advanced Melanoma

Epidemiology, Immunology and Clinical Characteristics of COVID-19 (EPIC3)